DHR

NYSE · Life Sciences Tools & Services

Danaher Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks

$230.16

-2.00 (-0.86%)

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 26 84%

Hold 5 16%

Sell 0 0%

Price Target

Analyst Price Target -31.3% upside

Low Target $107.89

Average Target $158.11

High Target $252.83

Current Price $230.16

Current
$230.16

Target
$158.11

$107.89 $158.11 avg $252.83

Scenario Analysis

Bear Case

$107.89

-53.1%

Low target

Base Case

$158.11

-31.3%

Avg target

Bull Case

$252.83

+9.8%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$242.80

-5.2% from high

52-Week Low

$160.93

+43.0% from low

50-Day SMA

$221.62

+3.9% vs SMA

200-Day SMA

$200.89

+14.6% vs SMA

RSI (14)

56.3

Neutral

Target vs 52W High

$158.11

-34.9% vs high

Peer Consensus — Life Sciences Tools & Services

Stock	Consensus	Analysts	Buy %	Target	Upside
TMO Thermo Fisher Scientific Inc	Strong Buy	34	79%	$369.21	-46.8%
DHR Danaher Corp	Strong Buy	31	84%	$158.11	-31.3%
A Agilent Technologies Inc	Buy	30	73%	$64.69	-62.4%
IQV Iqvia Holdings Inc	Strong Buy	26	92%	$82.96	-68.7%
WAT Waters Corp	Strong Buy	28	75%	$189.60	-59.0%
MTD Mettler-Toledo International	Hold	19	47%	$170.43	-90.2%
ILMN Illumina Inc	Hold	28	54%	$169.36	-19.2%
WST West Pharmaceutical Services	Strong Buy	21	95%	$136.24	-66.9%